Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma
- PMID: 12436453
- DOI: 10.1002/cncr.10962
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma
Comment on
-
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.Cancer. 2001 Nov 1;92(9):2247-58. doi: 10.1002/1097-0142(20011101)92:9<2247::aid-cncr1570>3.0.co;2-y. Cancer. 2001. PMID: 11745278 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
